![Kathleen Clarence-Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kathleen Clarence-Smith
Fondateur chez
Km Pharmaceutical Consulting LLC
Profil
Kathleen E.
Clarence-Smith is the founder of Prestwick Scientific Capital, Inc. (founded in 1996), OXIS Biotech, Inc. (founded in 2014), Georgetown Translational Pharmaceuticals, Inc. (founded in 2015), and Chase Pharmaceuticals Corp.
(founded in 2007).
She held the title of Chief Medical Officer at Chase Pharmaceuticals Corp.
from 2014 to 2016.
Dr. Clarence-Smith is also the founder of Prestwick Chemical, Inc., Prestwick Pharmaceuticals, Inc., and Km Pharmaceutical Consulting LLC.
She currently holds positions as Chairman at Chase Therapeutics Corp., Director at Riverside Pharmaceuticals Corp., Director at Westhaven Therapeutics Corp., Director at DAS Therapeutics, Inc., and Member at the American Academy of Neurology (since 1990).
Her former positions include Vice Chairman & President-Neurology Division at GT Biopharma, Inc. (2017-2018), Senior Director-CNS Clinical Development at Hoffmann-La Roche, Inc., and Research Analyst at Stanford Group Co. She was also the Head-CNS Group at Sanofi from 1980 to 1987.
Dr. Clarence-Smith obtained a doctorate degree from Université François-Rabelais de Tours.
Postes actifs de Kathleen Clarence-Smith
| Sociétés | Poste | Début |
|---|---|---|
Km Pharmaceutical Consulting LLC | Fondateur | - |
Chase Therapeutics Corp.
 Chase Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Engages in developing medications for treating neurodegenerative disorders | Président | - |
American Academy of Neurology
 American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Corporate Officer/Principal | 01/01/1990 |
Riverside Pharmaceuticals Corp.
 Riverside Pharmaceuticals Corp. MiscellaneousMiscellaneous Operates as a non-classified establishment | Directeur/Membre du Conseil | - |
Westhaven Therapeutics Corp. | Directeur/Membre du Conseil | - |
DAS Therapeutics, Inc.
 DAS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage pharmaceutical company | Directeur/Membre du Conseil | - |
Anciens postes connus de Kathleen Clarence-Smith
| Sociétés | Poste | Fin |
|---|---|---|
| GT BIOPHARMA, INC. | Directeur Général | - |
Chase Pharmaceuticals Corp.
 Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel medications for the treatment of Alzheimer’s disease | Fondateur | 01/01/2016 |
Stanford Group Co.
 Stanford Group Co. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/02/2009 |
| ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Formation de Kathleen Clarence-Smith
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
33
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
GT Biopharma, Inc.
 GT Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovering, developing and commercializing novel therapeutics | Health Technology |
Stanford Group Co.
Stanford Group Co. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Prestwick Pharmaceuticals, Inc.
 Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for diseases related to the central nervous system | Health Technology |
Chase Pharmaceuticals Corp.
Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel medications for the treatment of Alzheimer’s disease | Health Technology |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Université François-Rabelais de Tours
 Université François-Rabelais de Tours Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Academy of Neurology
American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Commercial Services |
Km Pharmaceutical Consulting LLC | |
Prestwick Scientific Capital, Inc. | |
Prestwick Chemical, Inc.
 Prestwick Chemical, Inc. Pharmaceuticals: OtherHealth Technology Founded in 1999, Prestwick Chemical, Inc. specializes in designing and providing a diverse range of chemical screening libraries to accelerate early drug discovery and enhance hit rates. The private company is based in Washington, DC. The company's offerings include the Prestwick Chemical Library® of mainly FDA-approved drugs, specialized collections for synergistic anticancer drug combinations, synthetic macrocyclic peptides for targeting protein interfaces, fragment-based drug discovery, purified natural plant-derived compounds, and exclusive drug-like compounds with favorable ADME-Tox profiles. The company supplies these libraries in ready-to-screen formats with guaranteed compound purity, stability, and resupply options, and also provides compound supply, analog searching, hit confirmation, structure-activity relationship analysis, and custom synthesis services for various therapeutic areas including oncology, CNS, cardiovascular, and antimicrobial research. | Health Technology |
OXIS Biotech, Inc.
 OXIS Biotech, Inc. BiotechnologyHealth Technology Develops prodrug therapeutic for the treatment of cancer | Health Technology |
Georgetown Translational Pharmaceuticals, Inc.
 Georgetown Translational Pharmaceuticals, Inc. Hospital/Nursing ManagementHealth Services Provides treatment for neuropathic pain, refractory epilepsies, the symptoms of myasthenia gravis, and motion sickness | Health Services |
Chase Therapeutics Corp.
Chase Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Engages in developing medications for treating neurodegenerative disorders | Health Technology |
Riverside Pharmaceuticals Corp.
Riverside Pharmaceuticals Corp. MiscellaneousMiscellaneous Operates as a non-classified establishment | Miscellaneous |
Westhaven Therapeutics Corp. | |
DAS Therapeutics, Inc.
DAS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage pharmaceutical company | Health Technology |
